Gilead Sciences
GILD
GILD
1,671 hedge funds and large institutions have $77.9B invested in Gilead Sciences in 2023 Q3 according to their latest regulatory filings, with 130 funds opening new positions, 680 increasing their positions, 628 reducing their positions, and 125 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,671
Holders Change
-18
Holders Change %
-1.07%
% of All Funds
26.64%
Holding in Top 10
31
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+6.9%
% of All Funds
0.49%
New
130
Increased
680
Reduced
628
Closed
125
Calls
$919M
Puts
$816M
Net Calls
+$103M
Net Calls Change
-$139M
Top Buyers
| 1 |
ClearBridge Investments
New York
|
+$218M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$121M |
| 3 |
Two Sigma Investments
New York
|
+$120M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$99.7M |
| 5 |
JPMorgan Chase & Co
New York
|
+$68.3M |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$212M |
| 2 |
Bank of New York Mellon
New York
|
-$155M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$126M |
| 4 |
Renaissance Technologies
New York
|
-$100M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$96.1M |
